BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7916009)

  • 1. Estramustine: a novel radiation enhancer in human carcinoma cells.
    Ryu S; Gabel M; Khil MS; Lee YJ; Kim SH; Kim JH
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):99-104. PubMed ID: 7916009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and biological studies of estramustine phosphate as a novel radiation sensitizer.
    Kim JH; Khil MS; Kim SH; Ryu S; Gabel M
    Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):555-7. PubMed ID: 8005815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estramustine sensitizes human glioblastoma cells to irradiation.
    Yoshida D; Piepmeier J; Weinstein M
    Cancer Res; 1994 Mar; 54(6):1415-7. PubMed ID: 8137240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethacrynic acid: a novel radiation enhancer in human carcinoma cells.
    Khil MS; Kim SH; Pinto JT; Kim JH
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):375-80. PubMed ID: 8567338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined antimicrotubule activity of estramustine and taxol in human prostatic carcinoma cell lines.
    Speicher LA; Barone L; Tew KD
    Cancer Res; 1992 Aug; 52(16):4433-40. PubMed ID: 1353706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro studies of Taxol as a radiation sensitizer in human tumor cells.
    Liebmann J; Cook JA; Fisher J; Teague D; Mitchell JB
    J Natl Cancer Inst; 1994 Mar; 86(6):441-6. PubMed ID: 7907149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estramustine-binding protein (EMBP) content in four different cell lines and its correlation to estramustine induced metaphase arrest.
    Eklöv S; Mahdy E; Wester K; Björk P; Malmström PU; Busch C; Nilsson S
    Anticancer Res; 1996; 16(4A):1819-22. PubMed ID: 8712706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation sensitization by estramustine studies on cultured human prostatic cancer cells.
    Eklöv S; Essand M; Carlsson J; Nilsson S
    Prostate; 1992; 21(4):287-95. PubMed ID: 1461806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of radiosensitization after paclitaxel treatment of three human carcinoma cell lines.
    Stromberg JS; Lee YJ; Armour EP; Martinez AA; Corry PM
    Cancer; 1995 May; 75(9):2262-8. PubMed ID: 7712434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of paclitaxel in combination with radiation on human head and neck cancer cells (ZMK-1), cervical squamous cell carcinoma (CaSki), and breast adenocarcinoma cells (MCF-7).
    Pradier O; Rave-Fränk M; Schmidberger H; Bömecke M; Lehmann J; Meden H; Hess CF
    J Cancer Res Clin Oncol; 1999; 125(1):20-7. PubMed ID: 10037273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro radiosensitization of human cervical carcinoma cells by combined use of 13-cis-retinoic acid and interferon-alpha2a.
    Ryu S; Kim OB; Kim SH; He SQ; Kim JH
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):869-73. PubMed ID: 9652851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity and cell-cycle effects of paclitaxel when used as a single agent and in combination with ionizing radiation.
    Gupta N; Hu LJ; Deen DF
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):885-95. PubMed ID: 9128966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen mustard induces cell cycle arrest of human epithelial ovarian cancer cell lines.
    Nathan JD; Keefe DL; Weinstein MA; Chen Z; Naftolin F
    J Soc Gynecol Investig; 1994; 1(1):97-103. PubMed ID: 9419755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of microtubule inhibitors-taxol, vinblastine and estramustine on the growth and p53 gene expression in the hormone independent human prostatic JCA-1 cells.
    Darby E; An S; Ng C; Hsieh TC; Mallouh C; Wu JM
    Anticancer Res; 1996; 16(6B):3647-52. PubMed ID: 9042236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiinvasive activity of estramustine on malignant MO4 mouse cells and on DU-145 human prostate carcinoma cells in vitro.
    Mareel MM; Storme GA; Dragonetti CH; De Bruyne GK; Hartley-Asp B; Segers JL; Rabaey ML
    Cancer Res; 1988 Apr; 48(7):1842-9. PubMed ID: 3349462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in radiation survival curve parameters in human tumor and rodent cells exposed to paclitaxel (Taxol).
    Liebmann J; Cook JA; Fisher J; Teague D; Mitchell JB
    Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):559-64. PubMed ID: 7911794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cell cycle redistribution in radiosensitization: implications regarding the mechanism of fluorodeoxyuridine radiosensitization.
    McGinn CJ; Miller EM; Lindstrom MJ; Kunugi KA; Johnston PG; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):851-9. PubMed ID: 7960987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to the antimitotic drug estramustine is distinct from the multidrug resistant phenotype.
    Speicher LA; Sheridan VR; Godwin AK; Tew KD
    Br J Cancer; 1991 Aug; 64(2):267-73. PubMed ID: 1892755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning and sequencing of human betaIII-tubulin cDNA: induction of betaIII isotype in human prostate carcinoma cells by acute exposure to antimicrotubule agents.
    Ranganathan S; Dexter DW; Benetatos CA; Hudes GR
    Biochim Biophys Acta; 1998 Jan; 1395(2):237-45. PubMed ID: 9473684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrotubule effects of estramustine, an antiprostatic tumor drug.
    Stearns ME; Tew KD
    Cancer Res; 1985 Aug; 45(8):3891-7. PubMed ID: 4016756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.